HAYWARD, Calif., Jan. 16, 2018 -- Biolog, Inc. announced today the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial function has, for many years, been on the wish list of researchers studying a wide range of human disorders. The new products, MitoPlate™ S-1 and MitoPlate™ I-1 are now available.
Mitochondria are organelles inside of human and other eukaryotic cells that produce most of the energy that cells need to survive and grow. They are very complex and are coded for by more than 1100 genes that are dynamically regulated. When different cell types have mitochondrial defects, it can lead to wide ranging energetics-related disorders including cancer and ageing, neurological disorders, metabolic disorders, and immuno-deficiencies.
Researchers have struggled to find good approaches to study mitochondria because they have lacked a comprehensive assay approach. Biolog’s preconfigured 96-well MitoPlates provide powerful new analytical tools. The MitoPlate S-1 measures metabolism of 31 substrates, most of which are metabolized via the mitochondria. The MitoPlate I-1 measures sensitivity of the mitochondria to 22 diverse mitochondrial inhibitors. Rate of energy production measurements are made and analyzed using Biolog’s OmniLog® instrument and companion software. MitoPlates can also be read using any microplate reader that offers kinetic reading capability; thus, making these assays accessible to most laboratories.
According to Barry Bochner, Biolog’s CEO, the new MitoPlate product line adds a major new capability to Biolog’s existing Phenotype MicroArray™ product line. Phenotype MicroArray technology provides thousands of live cell assays applicable to both microbial and human cells. The new MitoPlate assays further expand Biolog’s broad and unique portfolio with permeabilized cell mitochondrial assays. All of these assays can be read on the versatile OmniLog instrument.
Biolog will hold an informative MitoPlate webinar on January 23, 2018 at 10AM Pacific Standard Time. Details of the webinar can be found on the Biolog Events Page at: http://info.biolog.com/WB-2018-01-23-MitoPlate-Webinar-LP.html
Product information and details can be found at: http://www.biolog.com/products-static/mitochondrial_function_assays.php
About Biolog, Inc.
Biolog is a privately held company based in Hayward, CA, that continues to lead in the development of powerful new cell analysis tools for solving critical problems in biological, pharmaceutical, and biotechnological research and development. It is the world leader in phenotypic cell profiling. Biolog products are available worldwide, either directly from the company or through its extensive network of international distributors. Further information can be obtained at Biolog's website, www.biolog.com.
For more information contact: Susan Murphy (510) 785-2564 ext.360 [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Washington Post Publisher Will Lewis Steps Down After Layoffs
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



